[Clonal chromosome abnormalities in malignant hematological diseases using fluorescence in situ hybridization]. 1998

M Soto-Quintana, and A Rojas-Atencio, and H Chirino, and F Alvarez-Nava, and L Pineda-Del Villar, and K Urdaneta, and S González-Ferrer, and R González
Unidad de Genética Médica, Facultad de Medicina, Universidad del Zulia, Maracaibo, Venezuela.

Fluorescent in situ hybridization (FISH) is a rapid, sensitive and reliable method for the identification of complete chromosomes, or segments of them, during metaphase or nuclear interphase. The present study shows the results of the analysis of 32 bone marrow aspirates from patients with malignant hematological diseases (11 AML, 7 ALL, 12 CML and 2 CLL), referred to the Medical Genetics Unit of the Faculty of Medicine, Zulia University, Maracaibo, Venezuela between 1994 and 1996. All samples were studied by conventional and molecular techniques (FISH), using probes of total chromosomes, alpha-satellites and locus specific. In patients with AML and ALL and FISH technique detected clonal chromosomal abnormalities, that were not found by the conventional cytogenetic technique. Furthermore, the PML-alpha RARA complex was identified in the promyelocytic acute leukemias. The presence of the molecular complex ABL-BCR was also demonstrated in CML. The present study demonstrates the usefulness of the FISH technique in the detection of clonal chromosomal abnormalities, which are important when considering the clinical care of patients with these pathologies.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008297 Male Males
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002869 Chromosome Aberrations Abnormal number or structure of chromosomes. Chromosome aberrations may result in CHROMOSOME DISORDERS. Autosome Abnormalities,Cytogenetic Aberrations,Abnormalities, Autosome,Abnormalities, Chromosomal,Abnormalities, Chromosome,Chromosomal Aberrations,Chromosome Abnormalities,Cytogenetic Abnormalities,Aberration, Chromosomal,Aberration, Chromosome,Aberration, Cytogenetic,Aberrations, Chromosomal,Aberrations, Chromosome,Aberrations, Cytogenetic,Abnormalities, Cytogenetic,Abnormality, Autosome,Abnormality, Chromosomal,Abnormality, Chromosome,Abnormality, Cytogenetic,Autosome Abnormality,Chromosomal Aberration,Chromosomal Abnormalities,Chromosomal Abnormality,Chromosome Aberration,Chromosome Abnormality,Cytogenetic Aberration,Cytogenetic Abnormality
D002877 Chromosomes, Human Very long DNA molecules and associated proteins, HISTONES, and non-histone chromosomal proteins (CHROMOSOMAL PROTEINS, NON-HISTONE). Normally 46 chromosomes, including two sex chromosomes are found in the nucleus of human cells. They carry the hereditary information of the individual. Chromosome, Human,Human Chromosome,Human Chromosomes
D002999 Clone Cells A group of genetically identical cells all descended from a single common ancestral cell by mitosis in eukaryotes or by binary fission in prokaryotes. Clone cells also include populations of recombinant DNA molecules all carrying the same inserted sequence. (From King & Stansfield, Dictionary of Genetics, 4th ed) Clones,Cell, Clone,Cells, Clone,Clone,Clone Cell
D005260 Female Females

Related Publications

M Soto-Quintana, and A Rojas-Atencio, and H Chirino, and F Alvarez-Nava, and L Pineda-Del Villar, and K Urdaneta, and S González-Ferrer, and R González
January 2002, Methods in molecular medicine,
M Soto-Quintana, and A Rojas-Atencio, and H Chirino, and F Alvarez-Nava, and L Pineda-Del Villar, and K Urdaneta, and S González-Ferrer, and R González
March 1976, Ugeskrift for laeger,
M Soto-Quintana, and A Rojas-Atencio, and H Chirino, and F Alvarez-Nava, and L Pineda-Del Villar, and K Urdaneta, and S González-Ferrer, and R González
March 1996, The Japanese journal of human genetics,
M Soto-Quintana, and A Rojas-Atencio, and H Chirino, and F Alvarez-Nava, and L Pineda-Del Villar, and K Urdaneta, and S González-Ferrer, and R González
July 2000, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
M Soto-Quintana, and A Rojas-Atencio, and H Chirino, and F Alvarez-Nava, and L Pineda-Del Villar, and K Urdaneta, and S González-Ferrer, and R González
January 1999, Methods in molecular biology (Clifton, N.J.),
M Soto-Quintana, and A Rojas-Atencio, and H Chirino, and F Alvarez-Nava, and L Pineda-Del Villar, and K Urdaneta, and S González-Ferrer, and R González
January 1994, Methods in molecular biology (Clifton, N.J.),
M Soto-Quintana, and A Rojas-Atencio, and H Chirino, and F Alvarez-Nava, and L Pineda-Del Villar, and K Urdaneta, and S González-Ferrer, and R González
January 1998, The National medical journal of India,
M Soto-Quintana, and A Rojas-Atencio, and H Chirino, and F Alvarez-Nava, and L Pineda-Del Villar, and K Urdaneta, and S González-Ferrer, and R González
December 1995, Stem cells (Dayton, Ohio),
M Soto-Quintana, and A Rojas-Atencio, and H Chirino, and F Alvarez-Nava, and L Pineda-Del Villar, and K Urdaneta, and S González-Ferrer, and R González
January 2002, Journal of neuro-oncology,
M Soto-Quintana, and A Rojas-Atencio, and H Chirino, and F Alvarez-Nava, and L Pineda-Del Villar, and K Urdaneta, and S González-Ferrer, and R González
February 2013, Zhongguo shi yan xue ye xue za zhi,
Copied contents to your clipboard!